Theory Paper IIDrNB Cardiology – Theory Notes

CARDIAC AMYLOIDOSIS; DIFFERENTIAL DIAGNOSIS & EVIDENCE

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

ITHE CORE DIFFERENTIAL DIAGNOSIS (LEFT VENTRICULAR HYPERTROPHY PHENOCOPIES)

  • The Diagnostic Challenge: Because Cardiac Amyloidosis (CA) presents with concentric or asymmetric Left Ventricular Wall Thickening (12 mm or greater) and preserved ejection fraction, it is frequently misdiagnosed as other conditions causing increased LV wall thickness:
  • Hypertrophic Cardiomyopathy (HCM): The primary inherited sarcomeric phenocopy.
  • Hypertensive Heart Disease (HHD): The most common acquired pressure-overload phenocopy.
  • Severe Calcific Aortic Stenosis (AS): Both a hemodynamic mimic and a frequent concomitant dual pathology in elderly patients.
  • Metabolic and Lysosomal Storage Phenocopies: Anderson-Fabry Disease (GLA), Danon Disease (LAMP2), PRKAG2 Cardiomyopathy, and mitochondrial cardiomyopathies.

IIDIFFERENTIAL EVIDENCE: CARDIAC AMYLOIDOSIS VS. HYPERTROPHIC CARDIOMYOPATHY (HCM)

  • 12-Lead Electrocardiogram (The Voltage-to-Mass Discordance Rule):
    • Cardiac Amyloidosis: Classic discordance between thick LV walls on echocardiography and low QRS voltage in the limb leads (<=5 mm in all limb leads, or low Sokolow-Lyon voltage-to-mass ratio), accompanied by a “pseudo-infarction” QS pattern in anterior/inferior leads (in 50 to 70 percent of patients with normal coronaries) and AV conduction delay.
    • Sarcomeric HCM: Prominent high QRS voltages fulfilling LVH criteria, deep narrow lateral/inferior “dagger” Q waves (from septal hypertrophy), or giant negative precordial T waves (in Apical HCM).
    • 2D Speckle-Tracking Echocardiography (Strain Polar Map):
    • Cardiac Amyloidosis: Pathognomonic “Relative Apical Sparing” (“Cherry-on-Top” bull’s-eye sign)—severely depressed basal and mid-ventricular longitudinal strain with preserved apical strain (Relative Apical Longitudinal Strain ratio >= 1.0, validated by Phelan et al. with 93 percent sensitivity and 82 percent specificity for differentiating CA from HCM and aortic stenosis). Also shows concurrent RV free-wall thickening (>5 mm), interatrial septal and AV valve thickening, and a small pericardial effusion.
    • Sarcomeric HCM: Focal longitudinal strain reduction localized to the site of maximal septal or apical hypertrophy without a basal-to-apical gradient, plus Systolic Anterior Motion (SAM) of the mitral valve and dynamic LVOT obstruction.
    • Cardiac Magnetic Resonance (LGE Distribution and Gadolinium Kinetics):
    • Cardiac Amyloidosis: Global, diffuse circumferential subendocardial or transmural Late Gadolinium Enhancement (LGE) (often involving both atria and the RV) coupled with abnormal inversion-time (TI) nulling kinetics (the amyloid myocardium nulls before or at the same inversion time as the blood pool on the TI scout).
    • Sarcomeric HCM: Patchy, mid-wall focal LGE localized to the anterior and posterior Right Ventricular septal insertion (“hinge”) points and segments of maximal hypertrophy, with normal blood-pool nulling kinetics.

IIIDIFFERENTIAL EVIDENCE: CARDIAC AMYLOIDOSIS VS. HYPERTENSIVE HEART DISEASE (HHD)

  • Clinical and Structural Clues: HHD patients have long-standing severe hypertension without orthopedic red flags (carpal tunnel syndrome, spinal stenosis, biceps tendon rupture); in contrast, CA patients frequently exhibit spontaneous normalization of prior hypertension (“auto-cure”) and intolerance to ACEi/ARBs/Beta-blockers, alongside thickened AV valve leaflets, thickened interatrial septum, RV hypertrophy, and severe Grade III restrictive diastolic filling.
  • CMR Parametric Mapping (The ECV Cut-off):
    • Cardiac Amyloidosis: Extreme Extracellular Volume (ECV) expansion (>40 percent, often 50 to 70 percent) and markedly elevated Native T1 (>1,100 to 1,150 ms at 1.5T) caused by massive extracellular fibril deposition.
    • Hypertensive Heart Disease: Normal or only mildly elevated ECV (<30 to 32 percent) and mildly increased Native T1, because wall thickening in HHD is predominantly intracellular cardiomyocyte hypertrophy with mild reactive interstitial collagen.
Diagnostic Modality / Feature Cardiac Amyloidosis (AL / ATTR) Sarcomeric HCM Hypertensive Heart Disease (HHD) Anderson-Fabry Disease (GLA)
12-Lead ECG Low QRS voltage / LVH discordance; pseudo-infarct QS; AV block High LVH voltage; deep narrow “dagger” Q waves; giant T-wave inversion Normal or high LVH voltage with lateral repolarization strain High LVH voltage; short PR interval (early) -> AV block (late)
Echo 2D Strain (GLS) “Apical Sparing” (“Cherry-on-Top”) (Apical/[Basal+Mid] ratio >=1.0) Focal reduction in hypertrophied septum or apex (no apical sparing) Mild diffuse basal/global reduction Early basal inferolateral strain reduction
CMR LGE Pattern Global subendocardial or transmural LGE + abnormal TI nulling Patchy mid-wall LGE at RV insertion points & thickest wall Absent LGE or minimal non-specific mid-wall fibrosis Classic mid-wall / subepicardial basal inferolateral LGE
CMR Native T1 & ECV Very High Native T1 & Massive ECV (>40–55%) Mildly elevated Native T1 & ECV in scarred segments Mildly elevated Native T1; ECV <30–32% Pathognomonic LOW Native T1 (intracellular lipid) & normal ECV
Tc-99m PYP/DPD Scan Perugini Grade 2 or 3 in ATTR (with negative sFLC/SIFE/UIFE) Grade 0 (Negative) Grade 0 (Negative) Grade 0 (Negative)

IVDIFFERENTIAL AND DUAL PATHOLOGY: CARDIAC AMYLOIDOSIS AND SEVERE AORTIC STENOSIS

  • High Prevalence of Dual Pathology (Castaño et al. / Scully et al. / Nitsche et al., JACC 2021): Prospective bone-scintigraphy screening studies demonstrate that 11 to 16 percent of elderly patients (aged >=75 years) referred for TAVR have concomitant occult Wild-Type Transthyretin Cardiac Amyloidosis (AS-ATTR-CM), rising to up to 25 to 30 percent in the Paradoxical Low-Flow, Low-Gradient (LFLG) severe AS subgroup.
  • Clinical and Echocardiographic Red Flags for Dual AS + ATTR-CM (The RAISE Score):
    • R — Remodeling: Disproportionate concentric LV wall thickening (>14 to 16 mm) and severe diastolic dysfunction/biatrial enlargement out of proportion to the aortic valve gradient.
    • A — Age: Age >= 85 years.
    • I — Injury: Chronically elevated High-Sensitivity Troponin (hs-cTnT).
    • S — Systemic: History of Carpal Tunnel Syndrome, lumbar spinal stenosis, or biceps tendon rupture.
    • E — Electrical: Right Bundle Branch Block (RBBB) or Low QRS Voltage (low Sokolow-Lyon voltage-to-mass ratio).
    • Hemodynamic Phenotype: Classic presentation is Low-Flow, Low-Gradient Severe AS (Stroke Volume Index <35 mL/m2, Mean Gradient <40 mmHg, AVA <=1.0 cm2) with preserved or mildly reduced LVEF and impaired longitudinal strain (mitral annular S’ <=6 cm/s).
    • Pre-TAVR CT Myocardial Extracellular Volume (CT-ECV) and Bone Scintigraphy:
    • Opportunistic Pre-TAVR CT-ECV: Performing a 3-to-5-minute delayed equilibrium scan during routine pre-TAVR cardiac CT to measure Myocardial CT-ECV (cut-off >31 to 35 percent) reliably screens for concomitant cardiac amyloidosis without requiring a separate CMR.
    • Confirmation and Clinical Impact (TAVR is Still Beneficial): Confirmed via Tc-99m PYP/DPD SPECT + monoclonal light-chain exclusion. Multicenter outcome studies (Nitsche et al., JACC 2021) prove that TAVR significantly improves survival compared to medical therapy in dual AS + ATTR-CM (futility is avoided), and post-TAVR initiation of Tafamidis / Acoramidis addresses the underlying amyloid cardiomyopathy.

VDIFFERENTIAL EVIDENCE: CARDIAC AMYLOIDOSIS VS. ANDERSON-FABRY DISEASE

  • Pathophysiology and Systemic Clues: Anderson-Fabry Disease is an X-linked lysosomal storage disorder caused by deficiency of alpha-galactosidase A (GLA gene), resulting in intracellular accumulation of globotriaosylceramide (Gb3) inside cardiomyocytes, vascular endothelium, kidneys, and nerves. Extracardiac hallmarks include angiokeratomas (bathing-trunk distribution), cornea verticillata (whorl-like corneal opacities on slit-lamp exam), acroparesthesias (burning neuropathic pain in hands/feet), hypohidrosis, and proteinuric CKD.
  • Definitive CMR Differentiation (Native T1 Mapping):
    • Anderson-Fabry Disease: Because Gb3 is an intracellular glycosphingolipid (fat), Fabry disease uniquely exhibits a pathognomonic LOW Native T1 relaxation time on CMR parametric mapping with a normal ECV (until late-stage replacement fibrosis develops in the basal inferolateral wall, causing focal “pseudonormalization” of T1).
    • Cardiac Amyloidosis: Exhibits markedly ELEVATED Native T1 and massively expanded ECV (>40%) because amyloid fibrils accumulate in the extracellular matrix.

Key references

  • Phelan D, Collier P, Thavendiranathan P, et al.: Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis, Heart, 2012.
  • Nitsche C, Scully PR, Patel KP, et al.: Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis, Journal of the American College of Cardiology, 2021.
  • Garcia-Pavia P, Rapezzi C, Adler Y, et al.: Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases, European Heart Journal, 2021.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.